Revenue
2019
2020
2020
2021
2022
2023
2024
2025
Yubo International Biotech Ltd (YBGJ)
Price—Loading quote
Net income
2019
2020
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
Total cash / debt
CashTotal debt
2019
2020
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 · Dec 31 | 2020 · Feb 29 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12,353 | $3,470 | $604,676 | $104,283 | $1.2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | $0 | $0 |
| Gross profit | $8,165 | $2,648 | $419,185 | $52,652 | $820,647 | $1.2M | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $1.2M | $1.8M | $1.6M | $1.3M | $2.4M | $2.0M | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$1.2M | −$1.8M | −$1.2M | −$1.2M | −$1.5M | −$711,798 | −$29,000 | −$48,000 | −$58,000 | −$149,000 | −$63,000 | −$58,000 | −$55,000 | −$60,000 | −$47,000 | −$80,000 |
| EBITDAderived | −$1.0M | −$1.6M | −$1.0M | −$1.2M | −$1.5M | −$698,735 | — | — | — | — | — | — | — | — | — | — |
| Net income | −$1.1M | −$1.8M | −$1.2M | −$1.2M | −$1.5M | −$711,801 | −$134,000 | −$148,000 | −$144,000 | −$224,000 | −$130,000 | −$116,000 | −$106,000 | −$103,000 | −$84,000 | −$110,000 |
| Basic EPSper diluted share | — | — | — | — | — | $0.01 | -$0.11 | -$0.13 | -$0.12 | -$0.19 | -$0.11 | -$0.10 | -$0.09 | -$0.09 | -$0.07 | -$0.09 |
| Diluted EPSper diluted share | -$0.01 | -$0.02 | -$0.10 | — | — | $0.01 | -$0.11 | -$0.13 | -$0.12 | -$0.19 | -$0.11 | -$0.10 | -$0.09 | -$0.09 | -$0.07 | -$0.09 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 15, 2024Form 4 | Wang YangChief Executive Officer | SellClass A Common Stock · indirect | 2.00M | $0.12 | $240.0K | 17.21M |
| Jan 25, 2024Form 4 | CAO YULIN +1TenPercentOwner | SellClass A Common Stock | 380.2K | $0.30 | $114.1K | 19.93M |
| Jan 25, 2024Form 4 | CAO YULIN +1TenPercentOwner | SellClass A Common Stock | 2.06M | $0.30 | $617.3K | 20.31M |
| Jan 25, 2024Form 4 | CAO YULIN +1TenPercentOwner | SellClass A Common Stock | 426.7K | $0.30 | $128.0K | 22.37M |
| Jan 25, 2024Form 4 | CAO YULIN +1TenPercentOwner | SellClass A Common Stock | 86.9K | $0.30 | $26.1K | 22.79M |